CIM Investment Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Buy
+3,047
New +$165K 0.05% 259
2025
Q3
– Sell
-3,421
Closed -$246K – 260
2025
Q2
$246K Buy
3,421
+3
+0.1% +$151 0.05% 225
2025
Q1
$200K Sell
3,418
-3
-0.1% -$203 0.05% 215
2024
Q4
$246K Buy
3,421
+16
+0.5% +$1.18K 0.07% 204
2024
Q3
$272K Sell
3,405
-60
-2% -$4.51K 0.08% 197
2024
Q2
$248K Sell
3,465
-20
-0.6% -$1.47K 0.08% 202
2024
Q1
$245K Hold
3,485
– – 0.07% 227
2023
Q4
$269K Hold
3,485
– – 0.09% 218
2023
Q3
$237K Sell
3,485
-84
-2% -$6.64K 0.09% 224
2023
Q2
$291K Buy
3,569
+8
+0.2% +$643 0.1% 190
2023
Q1
$264K Buy
3,561
+173
+5% +$13.3K 0.1% 204
2022
Q4
$281K Sell
3,388
-96
-3% -$7.62K 0.11% 182
2022
Q3
$247K Hold
3,484
– – 0.11% 177
2022
Q2
$302K Sell
3,484
-20
-0.6% -$1.87K 0.13% 161
2022
Q1
$379K Buy
+3,504
New +$362K 0.13% 151

Other funds holding TECH

CIM Investment Management's TECH Position: Q2 2026 in Review

CIM Investment Management opened a new position in Bio-Techne (TECH) in Q2 2026: 3,047 shares worth $215K. The stake represents 0.05% of the portfolio and ranks #259 among its holdings. This is a return to the name: CIM Investment Management previously reported a position in TECH as recently as Q2 2025.

CIM Investment Management first reported a position in TECH in Q1 2022 and has held it in 15 quarters since. The position peaked at $379K in Q1 2022. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • CIM Investment Management held 3,047 shares of Bio-Techne worth $215K as of Q2 2026.
  • Bio-Techne was a new CIM Investment Management position in Q2 2026.
  • Bio-Techne made up 0.05% of CIM Investment Management's portfolio in Q2 2026, its #259 holding.
  • CIM Investment Management first reported a position in Bio-Techne in Q1 2022 and has held it in 15 quarters since.
  • CIM Investment Management's Bio-Techne position peaked at $379K in Q1 2022.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on CIM Investment Management's 13F filing for Q2 2026, filed 29 Sep 2026.